For ELDL-treated smooth muscle cells the top canonical pathways affected includes biological processes linked to cytokine activation (LPS/IL-1, IL17 signaling, IL-8 signaling), cell migration pathways (bladder cancer signaling, colorectal cancer signaling) and other (Fig. 3C). Here, IL17A is linked to colorectal cancer.